{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:55:41Z","timestamp":1775883341568,"version":"3.50.1"},"reference-count":21,"publisher":"Scientific Scholar","content-domain":{"domain":["clinicalimagingscience.org"],"crossmark-restriction":true},"short-container-title":["JCIS"],"abstract":"\n Objectives:<\/jats:title>\n The objective of the study is to investigate the diagnostic value of apparent diffusion coefficient (ADC) parameters in differentiating prostate cancer (PCa) pathology grading groups (GG) and their correlation with Ki-67 proliferation index.<\/jats:p>\n <\/jats:sec>\n \n Material and Methods:<\/jats:title>\n \n This single-center retrospective study analyzed magnetic resonance imaging data from 119 pathologically confirmed PCa cases with documented Ki-67 proliferation indices. Both mean ADC (ADC\n mean<\/jats:sub>\n ) and minimum ADC (ADC\n min<\/jats:sub>\n ) values were obtained from dominant lesions using ADC mapping. Comparative analysis was performed between high-risk PCa (hPCa) and non-high-risk PCa (nhPCa) groups. Diagnostic performance was assessed through receiver operating characteristic (ROC) curve analysis, while Spearman correlation was employed to evaluate relationships between ADC parameters, GG, and Ki-67 index.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Significantly lower ADC\n mean<\/jats:sub>\n and ADC\n min<\/jats:sub>\n values were observed in hPCa compared to nhPCa (\n P<\/jats:italic>\n < 0.001). ROC analysis demonstrated the diagnostic utility of ADC parameters in distinguishing hPCa from nhPCa. Both ADC\n mean<\/jats:sub>\n and ADC\n min<\/jats:sub>\n showed significant negative correlations with GG and Ki-67 proliferation index (\n P<\/jats:italic>\n < 0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n This study demonstrates an inverse correlation between ADC values and tumor proliferative activity in PCa, providing biological validation for DWI in assessing tumor aggressiveness. While this quantitative parameter shows potential for risk stratification, its application requires further multicenter validation.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/jcis_125_2025","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:25:52Z","timestamp":1775881552000},"page":"15","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apparent diffusion coefficient values in prostate cancer: Association with pathological grade groups and correlation with Ki-67 proliferation index"],"prefix":"10.25259","volume":"16","author":[{"given":"Yanqiu","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Radiology, The Central Hospital of Yongzhou, Yongzhou, Hunan Province, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linbo","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Central Hospital of Yongzhou, Yongzhou, Hunan Province, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Central Hospital of Yongzhou, Yongzhou, Hunan Province, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"10.25259\/JCIS_125_2025\/ref-1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.25259\/JCIS_125_2025\/ref-2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/JCIS_125_2025\/ref-3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/pros.24465","article-title":"The cribriform morphology impairs Gleason 7 prostate cancer lesion detection on multiparametric magnetic resonance imaging","volume":"83","author":"Kazan","year":"2023","journal-title":"Prostate"},{"key":"10.25259\/JCIS_125_2025\/ref-4","first-page":"20","article-title":"Quantitative evaluation of late gadolinium enhancement to the differential diagnosis of prostate cancer and prostatitis in mpMRI","volume":"33","author":"Aydin","year":"2023","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.25259\/JCIS_125_2025\/ref-5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41391-019-0158-x","article-title":"Financial implications of biparametric prostate MRI","volume":"23","author":"Porter","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.25259\/JCIS_125_2025\/ref-6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5152\/dir.2022.20732","article-title":"Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings","volume":"28","author":"Karaarslan","year":"2022","journal-title":"Diagn Interv Radiol"},{"key":"10.25259\/JCIS_125_2025\/ref-7","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.2147\/CMAR.S319306","article-title":"The assessment of prostate cancer aggressiveness using a combination of quantitative diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging","volume":"13","author":"Zhu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.25259\/JCIS_125_2025\/ref-8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mri.2020.01.011","article-title":"Correlation analysis of apparent diffusion coefficient value and P53 and ki-67 expression in esophageal squamous cell carcinoma","volume":"68","author":"Wang","year":"2020","journal-title":"Magn Reson Imaging"},{"key":"10.25259\/JCIS_125_2025\/ref-9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000346475","article-title":"Correlation between Ki67 and breast cancer prognosis","volume":"84","author":"Kontzoglou","year":"2013","journal-title":"Oncology"},{"key":"10.25259\/JCIS_125_2025\/ref-10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jmri.27283","article-title":"Comparison of biparametric and multiparametric MRI for clinically significant prostate cancer detection with PI-RADS version 2.1","volume":"53","author":"Tamada","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.25259\/JCIS_125_2025\/ref-11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTROESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.25259\/JCIS_125_2025\/ref-12","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00259-020-04995-5","article-title":"Detection of metastases in newly diagnosed prostate cancer by using 68GaPSMA PET\/CT and its relationship with modified D'amico risk classification","volume":"48","author":"Simsek","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.25259\/JCIS_125_2025\/ref-13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.crad.2008.02.001","article-title":"Diffusion-weighted magnetic resonance imaging: A potential non-invasive marker of tumour aggressiveness in localized prostate cancer","volume":"63","author":"deSouza","year":"2008","journal-title":"Clin Radiol"},{"key":"10.25259\/JCIS_125_2025\/ref-14","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s00330-019-06510-3","article-title":"Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI international breast diffusion-weighted imaging working group","volume":"30","author":"Baltzer","year":"2020","journal-title":"Eur Radiol"},{"key":"10.25259\/JCIS_125_2025\/ref-15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.21873\/anticanres.16163","article-title":"S-PI-RADS and PI-RRADS for biparametric MRI in the detection of prostate cancer and post-treatment local recurrence","volume":"43","author":"Scialpi","year":"2023","journal-title":"Anticancer Res"},{"key":"10.25259\/JCIS_125_2025\/ref-16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10334-021-00957-6","article-title":"Diffusion-weighted imaging in prostate cancer","volume":"35","author":"Tamada","year":"2022","journal-title":"MAGMA"},{"key":"10.25259\/JCIS_125_2025\/ref-17","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.21037\/qims-21-697","article-title":"A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer","volume":"12","author":"Yuan","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"10.25259\/JCIS_125_2025\/ref-18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1148\/radiol.13130973","article-title":"Prostate cancer aggressiveness: Assessment with whole-lesion histogram analysis of the apparent diffusion coefficient","volume":"271","author":"Donati","year":"2014","journal-title":"Radiology"},{"key":"10.25259\/JCIS_125_2025\/ref-19","doi-asserted-by":"publisher","first-page":"3111054","DOI":"10.1155\/2022\/3111054","article-title":"Analysis of apparent diffusion coefficient value and dynamic contrast-enhanced magnetic resonance imaging parameters of prostate cancer patients after diagnosis and treatment with magnetic resonance imaging","volume":"2022","author":"Gu","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.25259\/JCIS_125_2025\/ref-20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.euo.2018.12.006","article-title":"Correlations between apparent diffusion coefficient and Gleason score in prostate cancer: A systematic review","volume":"3","author":"Surov","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.25259\/JCIS_125_2025\/ref-21","doi-asserted-by":"publisher","first-page":"e041961","DOI":"10.1136\/bmjopen-2020-041961","article-title":"Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: A systematic review and meta-analysis","volume":"12","author":"Naheed","year":"2022","journal-title":"BMJ Open"}],"container-title":["Journal of Clinical Imaging Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/clinicalimagingscience.org\/apparent-diffusion-coefficient-values-in-prostate-cancer-association-with-pathological-grade-groups-and-correlation-with-ki-67-proliferation-index\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinicalimagingscience.org\/apparent-diffusion-coefficient-values-in-prostate-cancer-association-with-pathological-grade-groups-and-correlation-with-ki-67-proliferation-index\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:25:53Z","timestamp":1775881553000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalimagingscience.org\/apparent-diffusion-coefficient-values-in-prostate-cancer-association-with-pathological-grade-groups-and-correlation-with-ki-67-proliferation-index\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":21,"alternative-id":["10.25259\/JCIS_125_2025"],"URL":"https:\/\/doi.org\/10.25259\/jcis_125_2025","relation":{},"ISSN":["2156-5597","2156-7514"],"issn-type":[{"value":"2156-5597","type":"electronic"},{"value":"2156-7514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"article-number":"15"}}